A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these profiles privately for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a robust market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the drug there before directing buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Express Worries
However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.
Several experts stated the popularity for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Removal
Based on TikTok, the platform has taken down problematic material and prohibited related hashtags and search suggestions. The organization said it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Research also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or administering at residence.
After moments of joining one group, a vendor shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.
Item Information and Pricing
Within these groups, posts display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously seen individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may expose users to possibly significant medical dangers”.
